Skip to main content

CORRECTION article

Front. Allergy, 09 September 2022
Sec. Rhinology
Volume 3 - 2022 | https://doi.org/10.3389/falgy.2022.1001078

Corrigendum on: White paper on European patient needs and suggestions on chronic type 2 inflammation of airways and skin by EUFOREA

Louise De Prins1,2 Ulrike Raap3,4 Tara Mueller3,4 Peter Schmid-Grendelmeier1,5 Christiane H. Haase6 Vibeke Backer1,6 Wytske Fokkens1,7 Linda B. Benoist7 Emmanuel Prokopakis1,8 Maria Doulaptsi8 Claire Hopkins1,9 Nele Claeys10 Thijs Teeling10 Lindsay Cypers1* Leen Cools1,2 Leif H. Bjermer1 Zuzana Diamant1 Ulrich Wahn1 Glenis Scadding1 Claus Bachert11 Peter Walther1 Sunni R. Patel1 Elizabeth Van Staeyen1 Peter Hellings1,2,7,11
  • 1Department of Otorhinolaryngology, EUFOREA Scientific Expert Team Members, Brussels, Belgium
  • 2Department of Otorhinolaryngology, Head and Neck Surgery, Universitair Ziekenhuis Leuven, Leuven, Belgium
  • 3Division of Experimental Allergology and Immunodermatology, University of Oldenburg, Oldenburg, Germany
  • 4Department of Dermatology, Klinikum Oldenburg, University of Oldenburg, Oldenburg, Germany
  • 5Department of Dermatology, Allergy Unit, University Hospital of Zurich, Zurich, Switzerland
  • 6Department of Otorhinolaryngology Head and Neck Surgery and Audiology, Rigshospitalet, Copenhagen University, Copenhagen, Denmark
  • 7Department of Otorhinolaryngology, Head / Neck Surgery, Academic Medical Center (AMC), Amsterdam, Netherlands
  • 8Department of Otorhinolaryngology-Head and Neck Surgery, University of Crete School of Medicine, Heraklion, Crete, Greece
  • 9Department of Otorhinolaryngology, Guy’s and St Thomas’ Hospital, London Bridge Hospital, London, United Kingdom
  • 10EUFOREA Patient Advisory Board Chairs
  • 11Upper Airways Research Laboratory, Department of Otorhinolaryngology, University of Ghent, Ghent, Belgium

A corrigendum on

White paper on European patient needs and suggestions on chronic type 2 inflammation of airways and skin by EUFOREA

By De Prins L, Raap U, Mueller T, Schmid-Grendelmeier P, Haase CH, Backer V, Fokkens W, Benoist LB, Prokopakis E, Hopkins C, Claeys N, Teeling T, Cools LCL, Bjermer LH, Diamant Z, Wahn U, Scadding G, Bachert C, Patel SR, Van Staeyen E and Hellings P. (2022). Front. Allergy. 3:889221. doi: 10.3389/falgy.2022.889221

Error in author list

In the published article, there was an error in the author list, and authors Maria Doulaptsi and Peter Walther were erroneously excluded. The corrected author list appears below.

Louise De Prins1,2

Ulrike Raap3,4

Tara Mueller3,4

Peter Schmid-Grendelmeier1,5

Christiane H. Haase6

Vibeke Backer1,6

Wytske Fokkens1,7

Linda B. Benoist7

Emmanuel Prokopakis1,8

Maria Doulaptsi8

Claire Hopkins1,9

Nele Claeys10

Thijs Teeling10

Lindsay Cypers1*

Leen Cools1,2

Leif H. Bjermer1

Zuzana Diamant1

Ulrich Wahn1

Glenis Scadding1

Claus Bachert11

Peter Walther1

Sunni R. Patel1

Elizabeth Van Staeyen1

Peter Hellings1,2,7,11

The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.

Keywords: atopic dermatitis (AD), asthma, chronic rhinosinusitis, nasal polyps, type 2 inflammation, quality of life, unmet needs

Citation: De Prins L, Raap U, Mueller T, Schmid-Grendelmeier P, Haase CH, Backer V, Fokkens W, Benoist LB, Prokopakis E, Doulaptsi M, Hopkins C, Claeys N, Teeling T, Cypers L, Cools L, Bjermer LH, Diamant Z, Wahn U, Scadding G, Bachert C, Walther P, Patel SR, Van Staeyen E and Hellings P (2022) Corrigendum on: White paper on European patient needs and suggestions on chronic type 2 inflammation of airways and skin by EUFOREA. Front. Allergy 3:1001078. doi: 10.3389/falgy.2022.1001078

Received: 22 July 2022; Accepted: 22 August 2022;
Published: 9 September 2022.

Edited by:

Frontiers In Allergy Editorial Office, Frontiers Media SA, Switzerland

*Correspondence: Lindsay Cypers lindsay.cypers@euforea.eu

Specialty Section: This article was submitted to Rhinology, a section of the journal Frontiers in Allergy

© 2022 De Prins, Raap, Mueller, Schmid-Grendelmeier, Haase, Backer, Fokkens, Benoist, Prokopakis, Hopkins, Claeys, Teeling, Cypers, Cools, Bjermer, Diamant, Wahn, Scadding, Bachert, Patel, Van Staeyen and Hellings. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

Download